✦ LIBER ✦

Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: A mechanism for reducing clinical events?

✍ Scribed by Jerome D. Cohen; John H. Drury; Jamie Ostdiek; Jane Finn; B.R. Veerendra Babu; Gregory Flaker; Kathy Belew; Thomas Donohue; Arthur Labovitz

Book ID: 118508522
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 447 KB
Volume: 139
Category: Article
ISSN: 1097-6744
DOI: 10.1016/s0002-8703(00)90057-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trial suggests long term trapidil reduce

Trial suggests long term trapidil reduces cardiovascular events and improves prognosis in coronary artery disease: Abstracted from: Hirayama A, Kodama K, Yui Y et al. Effect of trapidil on cardiovascular events in patients with coronary artery disease (Results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]). Am J Cardiol 2003; 92: 789–93

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Effects of lipid lowering by pravastatin

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: The Regression Growth Evaluation Statin Study (REGRESS): J.W. Jukema, A.V.G. Bruschke, A.J. Van Boven, J.H.C. Reiber, E.T. Bal, A.H. Zwinderman, H. Jansen, G.J.M. Boerma, F.M. Van Rappard, K.I. Lie. Department of Cardiology, University Hospital Leiden, Leiden, The Netherlands. Circulation 1995;91: 2528–40

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 113 KB